New Zealand’s benchmark equity index finished the month with a flourish as Fisher & Paykel Healthcare shares surged, bringing the index’s November gain above 5 percent.

Fisher & Paykel Healthcare led the market higher as it recovered from a heavy bout of profit-taking after its annual result on Wednesday.

The S&P/NZX 50 Index ran out of puff after reaching elevated levels as investors booked profits on recent gains, and a resurgent kiwi dollar threatens to derail local export earnings.

Most New Zealand shares rose amid a flurry of mixed news from local companies and increasing confidence shown by offshore investors.

The Kiwi dollar lifted more than half a US cent after finance minister Grant Robertson proposed adding house prices to the RBNZ’s mandate, dashing any remaining expectations of interest rate cuts.

Most New Zealand shares rose as local retail data showed the largest quarterly rise since 1995, with investors taking the rebounding sales as a sign of ongoing economic recovery.

New Zealand's main share index fell as Ryman Healthcare’s weak half-year result took some heat out of the retirement village sector, while the soaring kiwi dollar put pressure on exporters.

The New Zealand share market dipped today as investors cashed in a number of stocks that had reached record highs in the two-week rally following the US election.

New Zealand’s benchmark equity index snapped an 11-day rally, falling from yesterday’s record close of 12,765 following negative market updates from A2 Milk, Serko and Napier Port.

New Zealand shares edged higher as a second promising vaccine caused investors to shift money into mid-size companies that have been slower to recover from the pandemic.

New Zealand shares and the kiwi dollar both gained as investors remained positive that a covid-19 vaccine could soon be available.

Fisher & Paykel Healthcare propped up an otherwise hesitant market as investors turned their attention back to the threat of the escalating global pandemic.

The New Zealand share market was flat as stock prices found a new level after a barrage of market moving news over the past 10 days.

The New Zealand dollar leapt to a 20-month high as the market reversed its bet the Reserve Bank will cut the official cash rate into negative territory.

Investors today sold recently top-performing stocks in favour of those worst affected by the covid-19 pandemic as news of an effective covid-19 vaccine prompted a massive rotation.

The kiwi dollar climbed to an 18-month high and New Zealand’s benchmark equity index closed at a new record as risk assets rallied in the wake of the US election results.